ABSTRACT
Myalgia and headache are relatively common in COVID-19 disease, but a serious neurological disease is uncommon. In this case, we describe the symptoms and clinic of AMSAN, a rare variant of Guillain Barre syndrome (GBS) due to COVID 19. We presented a case of AMSAN, a rare variant of GBS, in a 46-year-old male patient with poor overall condition that did not recover after COVID-19 disease, loss of strength and decreased sensation in distal limbs. electromyography-nerve conduction study findings were suggestive acute motor and sensory axonal neuropathy. Cerebrospinal fluid analysis was elevated protein with a normal white blood cell count. The clinical diagnosis of AMSAN supported by results of diagnostic testing such as cerebrospinal fluid and electromyography-nerve conduction study.